Casandra
Casandra Test Code MC95332Version 1 (DRAFT)
Performing Lab
Borrelia miyamotoi Detection PCR, Spinal Fluid
Clinical Use
Order TestUse
Aids in the diagnosis of Borrelia miyamotoi infection in conjunction with clinical findings. This test is not useful for detecting the Borrelia species that cause Lyme disease.
Special Instructions
The preferred method for detecting B miyamotoi is polymerase chain reaction. Testing algorithm available (Acute Tick‑Borne Disease Testing Algorithm).
Limitations
Less commonly, B miyamotoi spirochetes can be detected in cerebrospinal fluid preparations in patients with neurologic disease. Inadequate specimen collection or improper storage may invalidate test results. Borrelia miyamotoi DNA may be detectable for an unknown period after adequate treatment.
Test Details
New York Approved
Methodology
PCR-based (PCR)
Biomarkers
glpQ
GeneSNV/Indel • Mutation • Categorical (e.g., Positive / Negative / Indeterminate)
LOINC Codes
Order Codes
- 82476-3
Result Codes
- 82476-3
Result Turnaround Time
7 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Cerebrospinal Fluid
Volume
Not provided
Minimum Volume
0.3 mL
Stability Requirements
| Temperature | Period |
|---|---|
| Refrigerated | 7 days |
| Frozen | 7 days |